MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience

BACKGROUND AND PURPOSE: Chemoradiotherapy (CRT) followed by a brachytherapy (BT) boost is the standard of care for patients with locally advanced or recurrent gynecological cancer (LARGC). However, not every patient is suitable for BT. Therefore, we investigated the feasibility of an MR-guided SBRT...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadi, Indrawati, Eze, Chukwuka, Schönecker, Stephan, von Bestenbostel, Rieke, Rogowski, Paul, Nierer, Lukas, Bodensohn, Raphael, Reiner, Michael, Landry, Guillaume, Belka, Claus, Niyazi, Maximilian, Corradini, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760788/
https://www.ncbi.nlm.nih.gov/pubmed/35033132
http://dx.doi.org/10.1186/s13014-022-01981-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760788/
https://www.ncbi.nlm.nih.gov/pubmed/35033132
http://dx.doi.org/10.1186/s13014-022-01981-z

Ejemplares similares